三碘甲状腺乙酸与多种免疫分析法测定三碘甲状腺原氨酸的交叉反应
本研究将不同浓度(50-1,000 ng/dL)的三碘甲状腺乙酸(TRIAC)加入混合血清,在六个商业化平台检测总T3(TT3)和游离T3(FT3)。结果显示所有平台随TRIAC浓度升高均显著高估TT3和FT3,250 ng/dL TRIAC产生约190 ng/dL TT3的恒定干扰。结论:所有受试免疫分析法均与TRIAC显著交叉反应,接受TRIAC治疗者应改用非免疫分析法监测T3。
要点
- 所有受试TT3和FT3免疫分析法均与TRIAC显著交叉反应。
- 250 ng/dL TRIAC对TT3测定产生约190 ng/dL的恒定干扰。
- 接受TRIAC治疗的患者应使用非免疫分析法监测T3。
核心结论
- 所有受试的商业化TT3和FT3免疫分析法均与TRIAC发生显著交叉反应。
- 接受TRIAC治疗的患者应使用非免疫分析法监测T3反应,以避免误判甲状腺功能。
研究设计与样本
- 将50-1,000 ng/dL的TRIAC加入混合血清,在e602、Architect、Centaur、IMMULITE、DxI和Vitros平台上测定TT3和FT3。
- 在含恒定浓度TRIAC(250 ng/dL)的混合血清中加入递增T3进行TT3竞争实验。
主要发现
- 所有平台随TRIAC浓度升高均显著高估TT3和FT3。
- 250 ng/dL TRIAC对TT3测定产生约190 ng/dL的恒定干扰。
临床怎么用
- 接受TRIAC治疗的患者应避免使用免疫分析法监测T3,改用非免疫分析法。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Thyroid hormone analog 3,5,3'-triiodothyroacetic acid (TRIAC) is effective in reducing the hypermetabolism in monocarboxylate transporter 8 (MCT8)-deficient individuals. Because of the structural similarity between TRIAC and 3,3',5'-triiodothyronine (T3), we sought to investigate the degree of cross-reactivity of TRIAC with various commercially available total and free T3 assays. METHODS: Varying concentrations (50-1,000 ng/dL) of TRIAC (Sigma Aldrich) were added to pooled serum and assayed for total T3 (TT3) and free T3 (FT3) on the following platforms: e602 (Roche Diagnostics), Architect (Abbott Diagnostics), Centaur (Siemens Healthcare Diagnostics), IMMULITE (Siemens Healthcare Diagnostics), DxI (Beckman Coulter), and Vitros (Ortho Clinical Diagnostics). TT3 competition assay with TRIAC was performed by adding increasing amounts of T3 to pooled serum samples that contained a constant concentration of TRIAC (250 ng/dL). RESULTS: Significant overestimation of TT3 and FT3 assays were observed across all platforms corresponding to increasing concentrations of TRIAC. The TRIAC effect at 250 ng/dL showed a constant interference of approximately 190 ng/dL TT3. CONCLUSIONS: All commercial TT3 and FT3 assays tested in this work cross-react significantly with TRIAC. Therefore, patients undergoing TRIAC therapy should have T3 hormone response monitored using alternative nonimmunoassay-based methods to avoid misinterpretation of thyroid function profiles.
引用
- Chan SL, Refetoff S, Babic N, et al. Triiodothyroacetic Acid Cross-Reacts With Measurement of Triiodothyronine (T3) on Various Immunoassay Platforms. Am J Clin Pathol. 2022. PMID: 34542585. doi:10.1093/ajcp/aqab124
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。